These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 24670127)

  • 1. Visualization of angiogenesis during cancer development in the polyoma middle T breast cancer model: molecular imaging with (R)-[11C]PAQ.
    Samén E; Lu L; Mulder J; Thorell JO; Damberg P; Tegnebratt T; Holmgren L; Rundqvist H; Stone-Elander S
    EJNMMI Res; 2014 Mar; 4(1):17. PubMed ID: 24670127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and preclinical evaluation of [(11)C]PAQ as a PET imaging tracer for VEGFR-2.
    Samén E; Thorell JO; Lu L; Tegnebratt T; Holmgren L; Stone-Elander S
    Eur J Nucl Med Mol Imaging; 2009 Aug; 36(8):1283-95. PubMed ID: 19288096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment response assessment with (R)-[
    Tegnebratt T; Lu L; Eksborg S; Chireh A; Damberg P; Nikkhou-Aski S; Foukakis T; Rundqvist H; Holmin S; Kuiper RV; Samen E
    EJNMMI Res; 2018 Apr; 8(1):25. PubMed ID: 29616369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 32nd International Austrian Winter Symposium : Zell am See, the Netherlands. 20-23 January 2016.
    Langsteger W; Rezaee A; Loidl W; Geinitz HS; Fitz F; Steinmair M; Broinger G; Pallwien-Prettner L; Beheshti M; Imamovic L; Beheshti M; Rendl G; Hackl D; Tsybrovsky O; Steinmair M; Emmanuel K; Moinfar F; Pirich C; Langsteger W; Bytyqi A; Karanikas G; Mayerhöfer M; Koperek O; Niederle B; Hartenbach M; Beyer T; Herrmann K; Czernin J; Rausch I; Rust P; DiFranco MD; Lassen M; Stadlbauer A; Mayerhöfer ME; Hartenbach M; Hacker M; Beyer T; Binzel K; Magnussen R; Wei W; Knopp MU; Flanigan DC; Kaeding C; Knopp MV; Leisser A; Nejabat M; Hartenbach M; Kramer G; Krainer M; Hacker M; Haug A; Lehnert W; Schmidt K; Kimiaei S; Bronzel M; Kluge A; Wright CL; Binzel K; Zhang J; Wuthrick E; Maniawski P; Knopp MV; Blaickner M; Rados E; Huber A; Dulovits M; Kulkarni H; Wiessalla S; Schuchardt C; Baum RP; Knäusl B; Georg D; Bauer M; Wulkersdorfer B; Wadsak W; Philippe C; Haslacher H; Zeitlinger M; Langer O; Bauer M; Feldmann M; Karch R; Wadsak W; Zeitlinger M; Koepp MJ; Asselin MC; Pataraia E; Langer O; Zeilinger M; Philippe C; Dumanic M; Pichler F; Pilz J; Hacker M; Wadsak W; Mitterhauser M; Nics L; Steiner B; Hacker M; Mitterhauser M; Wadsak W; Traxl A; Wanek T; Kryeziu K; Mairinger S; Stanek J; Berger W; Kuntner C; Langer O; Mairinger S; Wanek T; Traxl A; Krohn M; Stanek J; Filip T; Sauberer M; Kuntner C; Pahnke J; Langer O; Svatunek D; Denk C; Wilkovitsch M; Wanek T; Filip T; Kuntner-Hannes C; Fröhlich J; Mikula H; Denk C; Svatunek D; Wanek T; Mairinger S; Stanek J; Filip T; Fröhlich J; Mikula H; Kuntner-Hannes C; Balber T; Singer J; Fazekas J; Rami-Mark C; Berroterán-Infante N; Jensen-Jarolim E; Wadsak W; Hacker M; Viernstein H; Mitterhauser M; Denk C; Svatunek D; Sohr B; Mikula H; Fröhlich J; Wanek T; Kuntner-Hannes C; Filip T; Pfaff S; Philippe C; Mitterhauser M; Hartenbach M; Hacker M; Wadsak W; Wanek T; Halilbasic E; Visentin M; Mairinger S; Stieger B; Kuntner C; Trauner M; Langer O; Lam P; Aistleitner M; Eichinger R; Artner C; Eidherr H; Vraka C; Haug A; Mitterhauser M; Nics L; Hartenbach M; Hacker M; Wadsak W; Kvaternik H; Müller R; Hausberger D; Zink C; Aigner RM; Cossío U; Asensio M; Montes A; Akhtar S; Te Welscher Y; van Nostrum R; Gómez-Vallejo V; Llop J; VandeVyver F; Barclay T; Lippens N; Troch M; Hehenwarter L; Egger B; Holzmannhofer J; Rodrigues-Radischat M; Pirich C; Pötsch N; Rausch I; Wilhelm D; Weber M; Furtner J; Karanikas G; Wöhrer A; Mitterhauser M; Hacker M; Traub-Weidinger T; Cassou-Mounat T; Balogova S; Nataf V; Calzada M; Huchet V; Kerrou K; Devaux JY; Mohty M; Garderet L; Talbot JN; Stanzel S; Pregartner G; Schwarz T; Bjelic-Radisic V; Liegl-Atzwanger B; Aigner R; Stanzel S; Quehenberger F; Aigner RM; Marković AK; Janković M; Jerković VM; Paskaš M; Pupić G; Džodić R; Popović D; Fornito MC; Familiari D; Koranda P; Polzerová H; Metelková I; Henzlová L; Formánek R; Buriánková E; Kamínek M; Thomson WH; Lewis C; Thomson WH; O'Brien J; James G; Notghi A; Huber H; Stelzmüller I; Wunn R; Mandl M; Fellner F; Lamprecht B; Gabriel M; Fornito MC; Leonardi G; Thomson WH; O'Brien J; James G; Hudzietzová J; Sabol J; Fülöp M
    EJNMMI Res; 2016 Apr; 6(Suppl 1):32. PubMed ID: 27090254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using dual-tracer PET to predict the biologic behavior of human colorectal cancer.
    Wang H; Zhang J; Tian J; Qu B; Li T; Chen Y; Liu J; Wang S
    J Nucl Med; 2009 Nov; 50(11):1857-64. PubMed ID: 19837754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring therapeutic efficacy of sunitinib using [(18)F]FDG and [(18)F]FMISO PET in an immunocompetent model of luminal B (HER2-positive)-type mammary carcinoma.
    Thézé B; Bernards N; Beynel A; Bouet S; Kuhnast B; Buvat I; Tavitian B; Boisgard R
    BMC Cancer; 2015 Jul; 15():534. PubMed ID: 26198000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative functional evaluation of immunocompetent mouse breast cancer models established from PyMT-tumors using small animal PET with [(18)F]FDG and [(18)F]FLT.
    Desilva A; Wuest M; Wang M; Hummel J; Mossman K; Wuest F; Hitt MM
    Am J Nucl Med Mol Imaging; 2012; 2(1):88-98. PubMed ID: 23133804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammary cancer bone metastasis follow-up using multimodal small-animal MR and PET imaging.
    Doré-Savard L; Barrière DA; Midavaine É; Bélanger D; Beaudet N; Tremblay L; Beaudoin JF; Turcotte EE; Lecomte R; Lepage M; Sarret P
    J Nucl Med; 2013 Jun; 54(6):944-52. PubMed ID: 23596003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multimodal In Vivo Imaging of Tumorigenesis and Response to Chemotherapy in a Transgenic Mouse Model of Mammary Cancer.
    Alberini JL; Boisgard R; Guillermet S; Siquier K; Jego B; Thézé B; Urien S; Rezaï K; Menet E; Maroy R; Dollé F; Kühnast B; Tavitian B
    Mol Imaging Biol; 2016 Aug; 18(4):617-26. PubMed ID: 26630973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positron emission tomography for prostate, bladder, and renal cancer.
    Schöder H; Larson SM
    Semin Nucl Med; 2004 Oct; 34(4):274-92. PubMed ID: 15493005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PET imaging of angiogenesis after myocardial infarction/reperfusion using a one-step labeled integrin-targeted tracer 18F-AlF-NOTA-PRGD2.
    Gao H; Lang L; Guo N; Cao F; Quan Q; Hu S; Kiesewetter DO; Niu G; Chen X
    Eur J Nucl Med Mol Imaging; 2012 Apr; 39(4):683-92. PubMed ID: 22274731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors.
    Jacobs AH; Thomas A; Kracht LW; Li H; Dittmar C; Garlip G; Galldiks N; Klein JC; Sobesky J; Hilker R; Vollmar S; Herholz K; Wienhard K; Heiss WD
    J Nucl Med; 2005 Dec; 46(12):1948-58. PubMed ID: 16330557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study of 11C-choline PET and [18F]fluorodeoxyglucose PET in the evaluation of lung cancer.
    Khan N; Oriuchi N; Zhang H; Higuchi T; Tian M; Inoue T; Sato N; Endo K
    Nucl Med Commun; 2003 Apr; 24(4):359-66. PubMed ID: 12673163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity of vascular and progenitor cell compartments in tumours from MMTV-PyVmT transgenic mice during mammary cancer progression.
    Smith MJ; Berger RW; Minhas K; Moorehead RA; Coomber BL
    Int J Exp Pathol; 2011 Apr; 92(2):106-16. PubMed ID: 21059124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of Early Response Monitoring and Prediction of Cancer Antiangiogenesis Therapy via Noninvasive PET Molecular Imaging Strategies of Multifactorial Bioparameters.
    Bao X; Wang MW; Luo JM; Wang SY; Zhang YP; Zhang YJ
    Theranostics; 2016; 6(12):2084-2098. PubMed ID: 27698942
    [No Abstract]   [Full Text] [Related]  

  • 17. 11C-acetate PET imaging of lung cancer: comparison with 18F-FDG PET and 99mTc-MIBI SPET.
    Higashi K; Ueda Y; Matsunari I; Kodama Y; Ikeda R; Miura K; Taki S; Higuchi T; Tonami H; Yamamoto I
    Eur J Nucl Med Mol Imaging; 2004 Jan; 31(1):13-21. PubMed ID: 14574513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholinergic PET imaging in infections and inflammation using
    Jørgensen NP; Alstrup AK; Mortensen FV; Knudsen K; Jakobsen S; Madsen LB; Bender D; Breining P; Petersen MS; Schleimann MH; Dagnæs-Hansen F; Gormsen LC; Borghammer P
    Eur J Nucl Med Mol Imaging; 2017 Mar; 44(3):449-458. PubMed ID: 27785538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual-biomarker imaging of regional cerebral amyloid load and neuronal activity in dementia with PET and 11C-labeled Pittsburgh compound B.
    Meyer PT; Hellwig S; Amtage F; Rottenburger C; Sahm U; Reuland P; Weber WA; Hüll M
    J Nucl Med; 2011 Mar; 52(3):393-400. PubMed ID: 21321269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of R-2-[
    Zhang Z; Liu S; Ma H; Nie D; Wen F; Zhao J; Sun A; Yuan G; Su S; Xiang X; Hu P; Tang G
    Mol Imaging Biol; 2019 Dec; 21(6):1127-1137. PubMed ID: 30847820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.